Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Luger

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Acta Dermato-Venereologica|November 20, 2024
Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb StudyLina Renkhold, Manuel P Pereira, Karin Loser, et al.
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trialRudolf Stadler, Thomas Luger, Thomas Bieber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 8, 2014
German psoriasis registry PsoBest: objectives, methodology and baseline dataMatthias Augustin, Christina Spehr, Marc A Radtke, et al.
Experimental Dermatology|June 18, 2016
Two olfactory receptors-OR2A4/7 and OR51B5-differentially affect epidermal proliferation and differentiationTeresa Tsai, Sophie Veitinger, Irina Peek, et al.
Acta Dermato-Venereologica|March 22, 2019
Direct and Indirect Effects of Crisaborole Ointment on Quality of Life in Patients with Atopic Dermatitis: A Mediation AnalysisEric L Simpson, Gil Yosipovitch, Andrew G Bushmakin, et al.
The Journal of Dermatology|May 8, 2021
Practical algorithm to inform clinical decision-making in the topical treatment of atopic dermatitisThomas Luger, Uladzimir Adaskevich, Maryna Anfilova, et al.
Pediatrics|March 25, 2015
Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trialBardur Sigurgeirsson, Andrzej Boznanski, Gail Todd, et al.
Dermatology and Therapy|February 3, 2023
Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian PerspectiveChia-Yu Chu, Tsung-Chieh Yao, I-Hsin Shih, et al.
The New England Journal of Medicine|June 15, 2016
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque PsoriasisKenneth B Gordon, Andrew Blauvelt, Kim A Papp, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 6, 2015
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infantsThomas Luger, Mark Boguniewicz, Warner Carr, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Acta Dermato-Venereologica|November 20, 2024
Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb StudyLina Renkhold, Manuel P Pereira, Karin Loser, et al.
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trialRudolf Stadler, Thomas Luger, Thomas Bieber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 8, 2014
German psoriasis registry PsoBest: objectives, methodology and baseline dataMatthias Augustin, Christina Spehr, Marc A Radtke, et al.
Experimental Dermatology|June 18, 2016
Two olfactory receptors-OR2A4/7 and OR51B5-differentially affect epidermal proliferation and differentiationTeresa Tsai, Sophie Veitinger, Irina Peek, et al.
Acta Dermato-Venereologica|March 22, 2019
Direct and Indirect Effects of Crisaborole Ointment on Quality of Life in Patients with Atopic Dermatitis: A Mediation AnalysisEric L Simpson, Gil Yosipovitch, Andrew G Bushmakin, et al.
The Journal of Dermatology|May 8, 2021
Practical algorithm to inform clinical decision-making in the topical treatment of atopic dermatitisThomas Luger, Uladzimir Adaskevich, Maryna Anfilova, et al.
Pediatrics|March 25, 2015
Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trialBardur Sigurgeirsson, Andrzej Boznanski, Gail Todd, et al.
Dermatology and Therapy|February 3, 2023
Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian PerspectiveChia-Yu Chu, Tsung-Chieh Yao, I-Hsin Shih, et al.
The New England Journal of Medicine|June 15, 2016
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque PsoriasisKenneth B Gordon, Andrew Blauvelt, Kim A Papp, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 6, 2015
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infantsThomas Luger, Mark Boguniewicz, Warner Carr, et al.
Pageof 11